Abstract A genetic factor that blocks the cannabinoid biosynthesis in Cannabis sativa has been investigated. Crosses between cannabinoid-free material and high content, pharmaceutical clones were performed. F 1 s were uniform and had cannabinoid contents much lower than the mean parental value. Inbred F 2 progenies segregated into discrete groups: a cannabinoid-free chemotype, a chemotype with relatively low cannabinoid content and one with relatively high content, in a monogenic 1:2:1 ratio. In our model the cannabinoid knockout factor is indicated as a recessive allele o, situated at locus O, which segregates independently from previously presented chemotype loci. The genotype o/o underlies the cannabinoid-free chemotype, O/o is expressed as an intermediate, low content chemotype, and O/O is the genotype of the high content chemotype. The data suggests that locus O governs a reaction in the pathway towards the phenolic cannabinoid precursors. The composition of terpenoids and various other compound classes of cannabinoid-free segregants remains unaffected. Backcrossing produced cannabinoid-free homologues of pharmaceutical production clones with potential applications in pharmacological research. A new variant of the previously presented allele 'B 0 ', that almost completely obstructs the conversion of CBG into CBD, was also selected from the source population of the cannabinoid knockout factor.
Introduction

Cannabinoid biogenesis
Cannabis plants accumulate cannabinoids as carboxylic acids in the secretory cavity of glandular trichomes. Here, these compounds will be indicated by the abbreviations for their neutral forms. The most common cannabinoids, those with pentyl side chains, are cannabidiol (CBD), delta 9-tetrahydrocannabinol (THC), cannabichromene (CBC) and cannabigerol (CBG). The first specific step in the pentyl cannabinoid biosynthesis is the condensation of the terpenoid moiety geranylpyrophosphate (GPP) with the phenolic moiety olivetolic acid (OA; 5-pentyl resorcinolic acid) into CBG. This reaction is catalysed by the enzyme geranylpyrophosphate:olivetolate geranyltransferase (GOT; Fellermeier and Zenk 1998) . Precursors for GPP are isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). These can originate from the mevalonate pathway (MVA) that is located in the cytoplasm and the deoxyxylulose pathway (DOX) that operates in the plastid compartments. According to Fellermeier et al. (2001) , the GPP incorporated into cannabinoids is derived via the DOX pathway of the glandular trichome plastids.The phenolic moiety OA is generated by a polyketide-type mechanism. Raharjo et al. (2004a) suggest that n-hexanoyl-CoA and three molecules of malonyl-CoA condense to a C 12 polyketide, which is subsequently converted into OA by a polyketide synthase. The condensation of n-hexanoylCoA and two, instead of three, molecules of malonylCoA, results in a C 10 polyketide. This is subsequently cyclisised into divarinic acid (DA; 5-propyl resorcinolic acid) by a polyketide synthase (Raharjo et al. 2004b) . Cannabinoids with propyl side chains result if GPP condenses with DA, into cannabigerovarin (CBGV).
CBG is the precursor for THC, CBD and CBC. For each CBG conversion an enzyme has been identified: THC acid synthase (Taura et al. 1995) , CBD acid synthase (Taura et al. 1996) and CBC acid synthase (Morimoto et al. 1997 (Morimoto et al. , 1998 . These enzymes are not selective for the length of the alkyl side chain and convert CBGV into the propyl homologues of CBD, THC and CBC, which are indicated as cannabidivarin (CBDV), delta 9-tetrahydrocannabivarin (THCV) and cannabichromevarin (CBCV), respectively (Shoyama et al. 1984) .
de Meijer et al. (2003) considered the total cannabinoid content as a polygenic character, that is heavily affected by the environment and shows a Gaussian distribution within the progenies described so far. The cannabinoid composition shows discrete distributions in segregating progenies and is under mono or oligogenic control. de Meijer et al. (2003) , de Meijer and Hammond (2005) 
Cannabinoid-free Cannabis
In the context of a Ukrainian fibre hemp breeding program, Gorshkova et al. (1988) examined the relationship between the morphology of glandular trichomes on the Cannabis bracteoles and the cannabinoid content. According to this report, plants lacking glandular trichomes and plants carrying trichomes with white heads contain no cannabinoids. Plants with transparent trichomes with heads in the yellow-orange to brown colour range were found to be rich in cannabinoids. Since then, Ukrainian plant breeders have reported several times on the existence of cannabinoid-free materials (Virovets et al. 1991 (Virovets et al. , 1997 Virovets 1998) . Pacifico et al. (2006) analysed individual plants from the cultivar USO-31 (Virovets 1996) and found that cannabinoids were undetectable in one-third of the individuals. The French fibre cultivar 'Santhica 23' was claimed to be devoid of cannabinoids, incorrectly indicated as alkaloids (Anonymous 1996) and in another French cultivar, Epsilon 68, Pacifico et al. (2006) could not detect cannabinoids in a minority of the plants (\10%).
A confusing paper by Sytnik and Stelmah (1999) may address the genetic mechanism underlying the cannabinoid-free chemotype. As outlined by Hillig (2002) , these authors do not consider cannabinoid composition independently and genetically distinct from the total cannabinoid content. Hillig interpreted their experiment as concerning a dihybrid cross between parents with contrasting total cannabinoid contents (low and high) and with contrasting cannabinoid compositions (low and high CBD/THC ratios). In an alternative understanding presented by Mandolino (2004) the paper's focus is on the segregation patterns of the discrete chemotypes 'with cannabinoids present' and 'without cannabinoids'. Following the latter interpretation, Sytnik and Stelmah found that a monogenic mechanism determines if the chemotype is with or without cannabinoids, and that the allele encoding cannabinoid presence dominates that encoding absence. While there are similar problems of interpretation with the paper by Virovets et al. (1997) , the same conclusion can be drawn from it. de Meijer et al. (2003) hypothesised an allelic locus A that governs the pathways to either CBG (A pe ) or CBGV (A pr ) and speculated that this same locus could also carry a 'null' allele preventing the cannabinoid synthesis.
Two physiological conditions could make a plant cannabinoid-free: (1) a disrupted morphogenesis of glandular trichomes that, according to Sirikantaramas et al. (2005) , are essential structures for cannabinoid synthesis, and (2) a blockage of one or more biochemical pathways that are crucial for the formation of precursors upstream of CBG. The first condition would seriously affect the synthesis of all other secondary metabolites that are produced largely or uniquely in the glandular trichomes. The second condition could also affect metabolites other than cannabinoids, as in the case of an obstruction of the basic pathways of common precursors for different classes of end products. Secondary metabolites other than cannabinoids will be referred to by the term 'entourage compounds'. In relation to Cannabis this term is used to indicate compounds that accompany the active constituents (i.e. cannabinoids) and may modulate their effects, yet without themselves having affinity for cannabinoid receptors.
Aim of this work
We aim to extend the genetic model for chemotype inheritance in Cannabis (de Meijer et al. 2003 de Meijer and Hammond 2005) . The previous papers focussed on the cannabinoid composition. Current emphasis is on the control of the discrete conditions of cannabinoid presence and absence. The wider biochemical implications related to cannabinoid absence are also considered. Table 1 lists the high content parental clones used in the experiments, which are all true breeding for their chemotype and Fig. 1 summarises the experiments. A seed sample of the Ukrainian fibre hemp cultivar USO-31 was obtained via Dr. G. Mandolino (Istituto Sperimentale per le Colture Industriali, Bologna, Italy). Of 23 plants grown from this sample, five appeared devoid of cannabinoids whereas the remaining ones contained variable contents ranging from traces (\0.01% w/w) up to 1.3% of the dry floral tissue. The cannabinoid fraction of the latter plants consisted of CBD, CBC and CBG. In one individual, CBG was the predominant cannabinoid and in all others it was CBD. From the point of view of cannabinoid production, all USO-31 plants had a very poor morphological appearance and it was not evident that plants in which cannabinoids were not detectable and those in which they were just so, belonged to different genotypes. Inbred seeds from the two relative best individuals, both with only a cannabinoid trace (0.01-0.02%) were pooled. This pool of inbred material was used to pollinate the high content clones M35 and M84. Apart from the inheritance of cannabinoid content, the cross with the THCV predominant M35 also investigated the possibility that a cannabinoid knockout factor may be an allele of a hypothesised locus that controls the cannabinoid alkyl chain length. A cannabinoid-free inbred F 3 line was selected from both of the resulting cross progenies and used in a backcrossing experiment with the pharmaceutical production clones M3 and M16. Large F 1 and inbred F 2 progenies were produced to allow a profound study of chemotype segregation. The practical objective of this backcrossing was to obtain cannabinoidfree homologues of the production clones.
Materials and methods
Plant materials and breeding experiments
Besides the monoecious USO-31, only female parents were used. In order to mutually cross and self-fertilise female plants, a partial masculinisation was chemically induced. Isolating plants in paper bags throughout the generative stage ensured selffertilisation. Distributions of chemotypes in segregating progenies were determined and v 2 values were calculated to test the conformity of observed segregation ratios to those expected on the basis of hypothesised models.
Cannabinoid analysis
Mature floral clusters from every individual plant considered in the breeding experiments were Further backcrossed to the relevant production clone to produce cannabinoid-free BC 2 s from which 'placebo clones' were selected sampled. Sample extraction, GC analysis, peak identification and quantification took place as described by de Meijer et al. (2003) . When it was opportune to confirm the true absence of cannabinoids, the standard analytical procedure was modified by increasing the sample weight, reducing the volume of the extraction solvent and reducing the split-ratio of the GC injector.
Chemical comparison of segregant bulks
The broader potential of the cannabinoid knockout factor to affect other compound classes was studied. For this purpose, per segregating F 2 , the floral leaves, bracts and bracteoles of all the cannabinoidfree plants were pooled and homogenised, as was the floral fraction of all the plants belonging to the group with high cannabinoid contents. The separate bulks from the 2005.45.13, 2005.46.27, 2005.47.9 and 2005.48 .7 F 2 s were steam-distilled and the essential oil yields assessed. The mono-and sesquiterpene composition of these essential oils was analysed by Gas Chromatography with Flame Ionisation Detection (GC-FID). The relative amounts of a wide range of entourage compounds in the bulk homogenates of the 2003.8.21 and 2003.17 .19 F 2 s were compared by using the techniques specified below. Of these, the cannabinoid and carotenoids assay methods are validated, the rest are R&D methods.
Gas Chromatography-Mass Spectrometry
To obtain comparative fingerprints, GC-MS analyses were performed on a HP5890 gas chromatograph, coupled to a VG Trio mass spectrometer. The GC was fitted with a Zebron fused silica capillary column (30 m 9 0.32 mm inner diameter) coated with ZB-5 at a film thickness of 0.25 lm (Phenomenex). The oven temperature was programmed from 70 to 305°C at a rate of 5°C/min. Helium was used as the carrier gas at a pressure of 55 kPa. The injection split ratio was 5:1.
Gas Chromatography with flame ionisation detection
GC profiles of terpenoids were generated in the splitless mode with a HP5890 gas chromatograph.
The GC was fitted with a Zebron fused silica capillary column (30 m 9 0.32 mm inner diameter) coated with ZB-624 at a film thickness of 0.25 lm (Phenomenex). The oven temperature was held at 40°C for 5 min, programmed to 250°C at a rate of 10°C/min then held at 250°C for 40 min. Helium was used as the carrier gas at a pressure of 9.2 psi. The injection split ratio was 10:1.
High-performance liquid chromatography with Ultra-Violet detection HPLC profiles were obtained using methods specific to a variety of compound classes. All samples were analysed using Agilent 1,100 series HPLC systems Cannabinoid profiles were generated using a C 18 (150 9 4.6 mm, 5 lm) analytical column. The mobile phase consisted of acetonitrile, 0.25% w/v acetic acid and methanol (75:20:5) at a flow rate of 1.0 ml/min and UV profiles were recorded at 220 nm. Carotenoid profiles were generated using a Varian Polaris C 18 (250 9 4.6 mm, 5 lm) analytical column. The mobile phase consisted of acetonitrile: methanol: dichloromethane: water at a flow rate of 1.2 ml/min and UV profiles were recorded at 453 nm. Chlorophyll profiles were generated using the same column, mobile phase and flow rate described for carotenoids. UV profiles were recorded at 660 nm. Non-polar compound profiles (triglycerides, sterols etc.) were generated by a gradient LC method using a Phenomenex Luna C 18 (2) (150 9 2.0 mm, 5 lm) analytical column. The mobile phase consisted of solvent A [acetonitrile: methyl-tert-butyl-ether (9:1)] and solvent B (water) with the proportion of B decreased linearly from 13 to 0% over 30 min then held constant for 20 min at a flow rate of 1.0 ml/min. The flow rate was then increased linearly to 1.5 ml/min over 40 min and UV profiles were recorded at 215 nm. Polar compound profiles (phenolics) were generated by a gradient LC method using an Ace C 18 (150 9 4.6 mm, 5 lm) analytical column. The mobile phase consisted of solvent A (acetonitrile: methanol, 95:5) and solvent B (0.25% w/v acetic acid: methanol, 95:5). The proportion of B was decreased linearly from 75 to 15% over 30 min then held constant for 10 min at a flow rate of 1.0 ml/min and UV profiles were recorded at 285 nm.
Results
Breeding experiments
Crosses between clones with high cannabinoid content and USO-31 offspring Twenty-four plants of the 2003.8 F 1 were evaluated. Twenty-one had cannabinoid contents, falling within a Gaussian distribution range from 1.13 to 4.56%. Three were distinct and had only trace amounts of cannabinoids, ranging from 0.02 to 0.15%. Similarly, the 19 plants of the 2003.17 F 1 comprised a majority of 17 individuals with a content range from 1.69 to 13.76%, and two plants with traces of only 0.02%. From both F 1 s, an individual with only a trace content was self-fertilised to produce an inbred F 2 (2003.8.21 and 2003.17.19) . The chemotype distributions of these F 2 s are presented in Table 2 . Both F 2 s comprised plants that were confirmed to be devoid of cannabinoids. The remaining plants, those with cannabinoids present, were assigned to two categories on the basis of what was thought to be a discontinuity in the cannabinoid content range: a group with low contents ranging from trace amounts up to roughly 0.6% and a group with higher contents. For the 2003.8.21 F 2 and over all, v 2 tests accepted a 1:2:1 segregation ratio. In the 2003.17.19 F 2 the low content group was overrepresented and a 1:2:1 segregation ratio was rejected.
Data on the dihybrid segregation of cannabinoid presence and composition (in terms of principal cannabinoid structures, irrespective of alkyl homologues) is summarised in plants had pure pentyl cannabinoid chemotypes (P C3 = 0) and in the other 11, P C3 ranged from 5.9 to 45.0%.
Crosses of confirmed cannabinoid-free lines with the production clones M3 and M16
The cannabinoid-free F 2 individuals, 2003.8.21.76 and 2003.17.19 .67, were self-fertilised to produce fixed cannabinoid-free F 3 lines for backcrossing to the production clones M3 and M16. Table 4 presents the total cannabinoid contents of the four resulting F 1 s. Within F 1 s, the cannabinoid contents showed a single Gaussian distribution and were much lower than the parental means. Per F 1 , one individual was selected through such criteria as resemblance to M3 or M16 and minimal monoeciousness (inherited from USO-31). To allow for further study of chemotype segregation, the selected F 1 individuals were selffertilised to produce large inbred F 2 progenies. Figure 2 presents the distribution of chemotypes in (high content-THC(V) predominant) were 24:54:41: 11:22:14, respectively. A 2:4:2:1:2:1 ratio, as expected in the case of independent dihybrid segregation, was accepted (v 2 = 8.687; threshold for acceptance at P = 0.05; v 2 \ 11.070). In this progeny P C3 also varied and ranged from 0 to 64.6% in the low content group and from 0 to 59.2% in the high content group. The P C3 distribution within the low and high content groups was similar. The total above ground dry weights of the cannabinoid-free and the high content segregants were assessed as an indication of vigour. Per F 2 progeny, per segregant group the weights showed a Gaussian distribution. In three progenies the cannabinoid-free individuals on average had a ca. 10% higher dry weight than the high content individuals. In the 2005.48.7 progeny however, the average weight of the high content group exceeded that of the cannabinoid-free group by about 10%.
Cannabinoid-free plants obtained in the course of the backcrossing program had increasingly more branching, a stronger fragrance and higher trichome density than the original USO-31 plants. In segregating progenies the different chemotypes were microscopically compared. Figure 3 shows images of different chemotypes in the 2005.45.13 F 2 . Bracteoles of cannabinoid-free plants all carried small, grey, dull trichomes of various shapes (Fig. 3a) . Some were headless; some were pinhead and shrivelled, either flat, convex or concave. The high content CBD-and/or THC-predominant individuals all had big, round clear heads that sparkled under the lamp (Fig. 3c) . The low content plants were almost indistinguishable from the cannabinoid-free plants except that their bracteoles showed an occasional small but bright trichome head (Fig. 3b) . The high content CBG predominant plants from the 2005.45.13 F 2 had big, round, opaque white heads (Fig. 3d) , clearly distinct from the transparent ones occurring on the THC predominant segregants of the same progeny. The low content CBG predominant 2005.45.13 plants did not show opaque white trichome heads and were indistinguishable from the low content THC predominant plants, neither were white trichome heads observed in any of the cannabinoid-free plants of this progeny.
The cannabinoid-free homologues that were selected from BC 2 generations, had a good semblance and fragrance of M3 and M16 but, unlike these 'originals', their mature inflorescences did not feel sticky.
Chemical comparison of cannabinoid-free and high content bulks
Yields and compositions of steam-distilled essential oils from bulked cannabinoid-free and bulked high content segregants of four F 2 progenies are presented in Table 6 . In three, the cannabinoid-free bulks contained less essential oil than the high content ones. In 2005.45.13, however, the cannabinoid-free bulk was slightly richer. No qualitative differences in the essential oil composition were found, only minor quantitative ones, which generally did not show a systematic pattern. The only consistent quantitative difference was found in caryophyllene oxide. In all four progenies it reached a higher proportion in the cannabinoid-free bulks than in the high content bulks. Limonene was an exception in that it was not detected in the cannabinoid-free bulks, whereas a minor presence was found in both of the high content bulks. However, the essential oil data in Table 6 does Table 7 does not show the difference in caryophyllene oxide as it appears in Table 6 . Both progenies in Table 7 had consistently higher levels of four different triglycerides in the cannabinoid-free bulks than the high content bulks. Of the entourage compounds listed in the Tables 6 and 7, the occurrence of none appears to be critically associated with the presence or absence of cannabinoids.
Discussion
Genetic mechanism
The breeding experiments have demonstrated that a cross between a cannabinoid-free plant and a high cannabinoid content plant yields an F 1 with low cannabinoid content. Inbred, these F 1 s produce F 2 s that segregate into the discrete chemotypes, 'cannabinoid-free', 'low content' and 'high content' in a 1:2:1 monogenic ratio. This tripartite segregation can also be presented in binary form, with the chemotypes 'cannabinoids absent' and 'cannabinoids present' appearing in a 1:3 ratio. Inbred offspring from cannabinoid-free plants invariably remained cannabinoid-free. These results can be explained by postulating a single allelic locus with a common functional allele that allows cannabinoid synthesis and a rare null-or knockout allele that obstructs it. The finding that ca. 25% of the F 2 plants was cannabinoid-free implies that the null allele is recessive and the functional dominant. However, the fact that, of the group with cannabinoids present, 2/3 of the plants had contents that were much lower than the parental mean, indicates that in heterozygotes, the null allele strongly suppresses the expression of the functional one. At least one of the two USO-31 source plants with only a trace of cannabinoids must have represented the genotype null/functional. The pooled inbred offspring from these plants, which were used to pollinate M35 and In a null/null genotype not even CBG and/or CBGV are detectable, so the null allele must operate upstream of the previously postulated locus B that controls the conversions of CBG(V) into THC(V) and CBD(V) de Meijer et al. (2003) and the accumulation of CBG(V) (de Meijer and Hammond 2005) as well as the fixed locus C that controls the conversion of CBG(V) into CBC(V) (de Meijer et al. 2009 ). The various dihybrid segregation ratios presented here indicate that the allelic locus regulating cannabinoid absence and presence segregates independently from locus B.
de Meijer et al. 2003 speculate that the postulated locus A, which governs the pathways towards either CBG (A pe ) or CBGV (A pr ), has a null allele responsible for blocking cannabinoid synthesis. The current results conflict with this theory. The USO-31 source plants which contained cannabinoids, had chemotypes composed solely of pentyl cannabinoids. This state, according to the theory, would make their locus A genotype A pe /A pe or A pe /A 0. Had the absence of cannabinoids in certain USO-31 plants been due to a null allele in the homozygous state at locus A, the genotype of these plants would have been A 0 /A 0. Table 6 Yield and composition of steam-distilled essential oil from bulked cannabinoid-free (Zero) and bulked high content segregants of four F 2 progenies. Oil yield is expressed as v/w (ml per 100 g of dry Botanical Raw Material, a mixture of stem leaves, floral bracts and bracteoles). Terpene amounts are presented as peak area % relative to the total peak area (set at 100%), tr. indicates that a constituent is detectable but under the quantification threshold. The terpenes were analysed by GC-FID-MS Table 7 The composition of bulked cannabinoid-free (Zero) and bulked high content segregants of two F 2 progenies. Cannabinoids, carotenoids, chlorophylls and triglycerides were analysed by HPLC-UV, other compounds by GC-FID-MS s, there were similar P C3 distributions in the low-and the high cannabinoid content segregant groups. This indicates that the factor that regulates cannabinoid presence/absence inherits independently from the factor that controls the proportions of alkyl homologues. We propose to situate the allele causing cannabinoid absence at a postulated locus 'O'. Locus O has the null allele o, which obstructs the cannabinoid synthesis in homozygous genotypes (o/o) and the functional allele O that fully allows cannabinoid synthesis in homozygous O/O plants. If a binary chemotype concept is used, only allowing for the conditions of 'cannabinoid presence' and 'cannabinoid absence', the functional allele dominates the null allele. This would concur with Mandolino's (2004) interpretation of the paper by Sytnik and Stelmah (1999) . However, all the F 1 plants resulting from contrasting crosses and about 50% of the plants in segregating F 2 s, had a cannabinoid content that was much closer to the zero value of the cannabinoid-free parent than to that of the high content parent. With a chemotype definition based on total cannabinoid content, one would consider the null allele as being incompletely dominant over the functional one.
It has been previously stated that the total cannabinoid content is a polygenic character, heavily affected by the environment and showing a Gaussian distribution within progenies (de Meijer et al. 2003) . This fully applies for progenies solely consisting of the common O/O plants. However, our model should include the distinction that, in o/o genotypes, the normal polygenic character of total cannabinoid content is overruled by the monogenic mechanism that dictates a discrete state of cannabinoid absence. In O/o genotypes this monogenic mechanism has a decisive, strongly suppressant effect on the degree of cannabinoid accumulation and leads to a discrete low content chemotype. Even so, within an O/o low content segregant group, the polygenic nature of total Morphological and biochemical effects of the cannabinoid knockout factor Cannabinoid-free segregants resulting from backcrosses with high content drug clones had stalked glandular trichomes in normal densities, but the trichome heads were dull and much smaller than those of their high cannabinoid content sister plants. Nevertheless, the trichomes of cannabinoid-free segregants appear to be functional metabolic organs. Chemical comparison of contrasting segregant bulks did not reveal big differences in the content and composition of volatile terpenes, the production of which requires functional trichomes. The absence of cannabinoids is probably the cause of the small trichome heads, rather than being a result of them.
The bracts and bracteoles of low content plants were microscopically almost indistinguishable from the cannabinoid-free plants except that they showed an occasional small but bright trichome head. In these plants the small amount of cannabinoids appears to be concentrated in just a few inflated trichomes and not evenly distributed throughout. Cannabinoids are synthesised in the trichome secretory cavities (Sirikantaramas et al. 2005) and translocation from there is unlikely. This implies that in O/o plants, the ability to synthesise cannabinoids is confined to a small minority of the trichomes. The abundant presence of apparently functional trichomes on our cannabinoid-free plants obtained through (back)crossing with high content materials, rules out the idea that the absence of cannabinoids is due to (1) a disrupted morphogenesis of the glandular trichomes. Hence it appears that the cannabinoid knockout factor is not derived from the gland-free plants reported by Gorshkova et al. (1988) . It is more likely that the absence of cannabinoids is attributable to the blockage of one or more biochemical pathways that are crucial for the formation of precursors upstream of CBG. As the chemical entourage of cannabinoid-free plants is intact, the obstacle is probably not in (2) the DOX pathway towards IPP. According to Fellermeier et al. (2001) the IPP incorporated into cannabinoids via GPP is derived from the DOX pathway in the plastids. Monoterpenes, diterpenes (phytol) and carotenoids are also uniquely synthesised in the plastids (Samuelsson 1999) and so one could conclude that the IPP incorporated in these compounds, as with cannabinoids, is derived from the DOX pathway. Therefore, if the absence of cannabinoids were due to a blockage of the DOX pathway that hampered the synthesis of the GPP, there should also be a negative effect on the synthesis of monoterpenes, (3), is that the knockout allele encodes a defective form of the enzyme GOT (Fellermeier and Zenk 1998) which catalyses the condensation of resorcinolic acids (OA and DA) with GPP into CBG(V). However, with such a mechanism one would expect an accumulation of OA and/or DA in the cannabinoid-free segregants. Our GC method for cannabinoid analysis detects the decarboxylated forms of both acids but they were not observed in any of the cannabinoid-free chromatograms. The most plausible hypothesis for the absence of cannabinoids therefore appears to be (4), a blockage in the polyketide pathway towards the phenolic moieties OA and DA. Whatever the mechanism of the cannabinoid knockout factor is, one would expect that a functional system would dominate a non-functional one, and so it remains obscure as to why the heterozygous genotypes (O/o) have such heavily suppressed cannabinoid synthesis. The essential oil comparison and the chromatographic fingerprinting of contrasting segregant bulks demonstrated that, except for the cannabinoids, all the compound classes monitored were present in both segregant groups. The levels of the compounds did vary between the contrasting segregant groups but not usually systematically. The quantitative differences between contrasting bulks could be attributable to the fact that, in cannabinoid-free plants, the trichome heads, as the metabolic centres for a range of endproducts, are not inflated with cannabinoids. This may change the physical environment in which the reactions occur so as to quantitatively affect the synthesis of entourage compounds. Large amounts of unincorporated basic cannabinoid precursors may also affect the equilibriums of other biosynthetic reactions.
It was noticed that although the cannabinoid-free homologues closely resemble the two production clones, their mature inflorescences do not feel sticky. The resinous stickiness that is typical of the floral leaf surface of common Cannabis plants is apparently caused by the mixture of cannabinoids and terpenes. If cannabinoids are missing, the plants have a dry surface.
Ecological and evolutionary implications
In heterozygous genotypes (O/o), the knockout allele strongly suppresses the cannabinoid synthesis, so it would be very conspicuous were it to be introduced into normally high content drug type populations. Over time, due to long distance wind pollination, such introgressions are likely, so it is remarkable that there are, apart from a few papers on fibre hemp, no references to the knockout factor. One could speculate as to whether this mutation is natural yet extremely rare, or recently man-made. Various theories, all relating to the defence against biotic and abiotic stress (Pate 1998) , attribute ecological benefits to the presence of cannabinoids which would explain the rarity of the knockout allele. Recently, Morimoto et al. (2007) reported on the ability of cannabinoids to induce necrotic cell death in the Cannabis leaf cells. They suggested that these compounds play a role in the plant's defence system and in the process of leaf senescence. Appendino et al. (2008) reported potent antibacterial effects for the major cannabinoids. In our glasshouse experiments, the absence of cannabinoids did not obviously weaken the plants nor affect the self-fertility in inbreeding cycles. In three out of four segregating progenies, the cannabinoid-free individuals actually produced, on average, more biomass than the high cannabinoid content individuals.
Practical applications
Apart from its utilisation in fibre hemp breeding, the knockout allele may also be of use in the development of Cannabis based pharmaceuticals. Cannabinoid-free clones with a non-cannabinoid entourage closely resembling that of pharmaceutical clones would provide suitable placebo material for clinical trials. They would also allow experiments focusing on cannabinoid-entourage interactions. To this purpose, we have developed a range of cannabinoid-free clones with mutually contrasting monoterpene compositions, the data of which are not presented here.
Updated genetic model
We have extended the genetic model for the regulation of Cannabis chemotype by introducing a locus O, with a dominant functional allele 'O' that allows normal cannabinoid synthesis in O/O homozygotes, and a recessive null allele 'o' that blocks the cannabinoid synthesis in o/o homozygotes and strongly suppresses it in O/o heterozygotes. In the sequence of biosynthetic events from precursors to cannabinoid end products, locus O undoubtedly operates upstream of CBG(V). The most plausible explanation appears that o blocks the polyketide pathway towards olivetolic-and divarinic acid. Locus O is independent from the previously presented loci B and C and from a genetic factor that governs the alkyl chain length of cannabinoids. In order to complete the inheritance model for the currently known cannabinoid chemotypes (Fig. 4) , the genetic control of the cannabinoid alkyl chain length remains to be investigated.
